LIVN
LivaNova PLC
+0.07 (+0.09%)78.58USD121K成交股數4.3B市值23.2本益比(近四季)2.9股價營收比+10.8%營收年增(近四季)2026-11-04下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 391M+11% | 362M+14% | 361M+13% | 358M+12% | 353M+20% | 317M+2% | 318M+11% | 319M+8% | 295M | 310M | 286M | 294M |
| 營業成本 | 117M | 119M | 121M | 113M | 114M | 101M | 97.1M | 104M | 91.7M | 135M | 84.3M | 88.7M |
| 毛利 | 274M+15% | 244M+13% | 240M+8% | 245M+14% | 239M+18% | 216M+24% | 221M+10% | 215M+5% | 203M | 175M | 202M | 205M |
| 毛利率 | 70.1% | 67.3% | 66.4% | 68.4% | 67.8% | 68.3% | 69.5% | 67.4% | 68.9% | 56.3% | 70.5% | 69.8% |
| 研發費用 | 53.7M | 58.7M | 52.1M | 48.6M | 47.2M | 37.9M | 48.8M | 44.7M | 45.7M | 46.2M | 46.5M | 51.1M |
| 銷售管理費用 | 158M | 144M | 143M | 139M | 138M | 129M | 127M | 125M | 126M | 118M | 135M | 126M |
| 營業利益 | 49.5M-9% | 41.5M-15% | 42.6M+20% | 54.0M+34% | 54.2M+234% | 48.6M-155% | 35.6M+699% | 40.2M+131% | 16.2M | −88.0M | 4.5M | 17.4M |
| 營業利益率 | 12.7% | 11.4% | 11.8% | 15.1% | 15.4% | 15.3% | 11.2% | 12.6% | 5.5% | -28.4% | 1.6% | 5.9% |
| 稅後淨利 | 109M+300% | 22.3M-107% | 30.9M-6% | 26.8M+64% | 27.2M-165% | −327M-2097% | 33.0M-550% | 16.3M+1314% | −41.9M | 16.4M | −7.3M | 1.2M |
| 淨利率 | 27.8% | 6.2% | 8.6% | 7.5% | 7.7% | -103.3% | 10.4% | 5.1% | -14.2% | 5.3% | -2.6% | 0.4% |
| 稀釋 EPS | 1.93+286% | 0.40-107% | 0.57-5% | 0.49+63% | 0.50-164% | -6.01-2103% | 0.60-529% | 0.30+1400% | -0.78 | 0.30 | -0.14 | 0.02 |
| 稀釋股數 | 56.3M | 55.9M | 54.5M | 55.2M | 54.7M | 54.4M | 54.6M | 54.6M | 54.0M | 54.2M | 54.0M | 54.0M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 517M | 540M | 636M | 646M | 594M | 738M | 346M | 329M | 309M | 267M | 234M | 223M |
| 應收帳款 | 231M | 229M | 216M | 212M | 220M | 202M | 197M | 201M | 209M | 215M | 190M | 186M |
| 存貨 | 173M | 166M | 165M | 168M | 165M | 154M | 162M | 155M | 153M | 148M | 162M | 156M |
| 總資產 | 2.6B | 2.5B | 2.6B | 2.6B | 2.5B | 2.6B | 2.5B | 2.5B | 2.5B | 2.4B | 2.3B | 2.3B |
| 有息負債 | 290M | 285M | 345M | 349M | 348M | 549M | 604M | 605M | 605M | 569M | 568M | 568M |
| 總負債 | 1.3B | 1.3B | 1.4B | 1.4B | 1.4B | 1.5B | 1.2B | 1.2B | 1.2B | 1.2B | 1.1B | 1.1B |
| 股東權益 | 1.3B | 1.2B | 1.2B | 1.2B | 1.1B | 1.0B | 1.3B | 1.2B | 1.2B | 1.3B | 1.2B | 1.2B |
| 負債比 | 49.8% | 51.9% | 54.0% | 54.8% | 55.2% | 59.6% | 48.1% | 49.3% | 50.3% | 47.4% | 47.4% | 47.0% |
| 淨現金(現金 − 有息負債) | 227M | 255M | 290M | 297M | 245M | 189M | −258M | −276M | −296M | −302M | −334M | −345M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 15.2M-37% | – | – | – | 24.0M | – | – | 10.0M | – | – | – |
| 資本支出 | – | 14.3M | – | – | – | 10.8M | – | – | 6.4M | – | – | – |
| 自由現金流 | – | 926K-93% | – | – | – | 13.2M | – | – | 3.6M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | 0.3% | – | – | – | 4.2% | – | – | 1.2% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 1.4B
| Cardiopulmonary | 785M | 57.0% | +14.9% |
|---|---|---|---|
| Neuromodulation | 593M | 43.0% | +7.0% |
地區2025 年度 · 1.4B
| 美國 | 740M | 51.2% | +6.4% |
|---|---|---|---|
| Locations Excluding The United States And Europe | 379M | 26.3% | +12.1% |
| 歐洲 | 269M | 18.6% | +22.3% |
| 英國 | 55.9M | 3.9% | +14.3% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 1.4B | +10.7% | −243M | -17.5% | -4.45 | 173M |
| FY2024 | 1.3B | +8.7% | 63.2M | 5.0% | 1.16 | 136M |
| FY2023 | 1.2B | +12.9% | 17.6M | 1.5% | 0.32 | 39.9M |
| FY2022 | 1.0B | -1.3% | −86.2M | -8.4% | -1.61 | 43.4M |
| FY2021 | 1.0B | +10.8% | −136M | -13.1% | -2.68 | 77.1M |
| FY2020 | 934M | -13.8% | −349M | -37.3% | -7.18 | −114M |
| FY2019 | 1.1B | -2.1% | −158M | -14.5% | -3.26 | −116M |
| FY2018 | 1.1B | – | −189M | -17.1% | -3.91 | 83.3M |